Observational Study About the Use of Fibrinogen in Adult Cardiac Surgery
FibCard Study: Observational Study About the Use of Fibrinogen in Adult Cardiac Surgery
Sponsor: Keyrus Biopharma
This observational or N/A phase trial investigates Cardiac Surgery and Extracorporeal Circulation and is currently ongoing. Keyrus Biopharma leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Apr 2019 — Jan 2021 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Jun 2018 — Apr 2019 [monthly]
Not Yet Recruiting
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Apr 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Mar 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Keyrus Biopharma
- Société Française d'Anesthésie et de Réanimation
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.